Roger Prades

Barcelona Science Park
Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Apolipoprotein E-enriched protein corona enhances the blood-brain barrier transport of β-sheet-breaker peptide-functionalized gold nanoparticles.

Apolipoprotein E-enriched protein corona enhances the blood-brain barrier transport of β-sheet-breaker peptide-functionalized gold nanoparticles.

Journal: Colloids and surfaces. B, Biointerfaces

Published: September 10, 2025

New Trends in Brain Shuttle Peptides.

New Trends in Brain Shuttle Peptides.

Journal: Molecular pharmaceutics

Published: February 03, 2025

Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization.

Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization.

Journal: Atherosclerosis

Published: February 21, 2024

Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia.

Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia.

Journal: International journal of molecular sciences

Published: November 29, 2022

The Gelatinase Inhibitor ACT-03 Reduces Gliosis in the Rapid Kindling Rat Model of Epilepsy, and Attenuates Inflammation and Loss of Barrier Integrity In Vitro.

The Gelatinase Inhibitor ACT-03 Reduces Gliosis in the Rapid Kindling Rat Model of Epilepsy, and Attenuates Inflammation and Loss of Barrier Integrity In Vitro.

Journal: Biomedicines

Published: May 29, 2022

Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds.

Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds.

Journal: Scientific reports

Published: September 14, 2021

The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects.

The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects.

Journal: The Journal of clinical investigation

Published: March 20, 2020

Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors.

Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors.

Journal: Bioorganic chemistry

Published: June 17, 2019

Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation.

Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation.

Journal: Biochimica et biophysica acta. Biomembranes

Published: January 20, 2019

A MALDI-TOF-based Method for Studying the Transport of BBB Shuttles-Enhancing Sensitivity and Versatility of Cell-Based In Vitro Transport Models.

A MALDI-TOF-based Method for Studying the Transport of BBB Shuttles-Enhancing Sensitivity and Versatility of Cell-Based In Vitro Transport Models.

Journal: Scientific reports

Published: June 29, 2018

Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics.

Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics.

Journal: Cell chemical biology

Published: February 01, 2018

HAI Peptide and Backbone Analogs-Validation and Enhancement of Biostability and Bioactivity of BBB Shuttles.

HAI Peptide and Backbone Analogs-Validation and Enhancement of Biostability and Bioactivity of BBB Shuttles.

Journal: Scientific reports

Published: December 05, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026